Marshall R. Sack
Marshall R. Sack publishes mostly in Rheumatology, Pharmacology and Pharmacology, on topics such as Rheumatoid Arthritis Research and Therapies, Inflammatory mediators and NSAID effects and Pharmacogenetics and Drug Metabolism.
- World rank
- #2,213,311 of 7,710,434 ranked researchers
- Rank in United States
- #663,562 of 1,627,098
- Works
- 18
- Citations
- 1.1k
- Citations per work
- 60.4
What does Marshall R. Sack research?
Marshall R. Sack's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (8%), Pharmacology, Toxicology and Pharmaceutics (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences950.0%
- Medicine950.0%
- Everything else634.0%
- Life Sciences316.0%
- 1Rheumatology20% of their works
- 2Pharmacology16% of their works
- 3Pharmacology8% of their works
- 4Molecular Biology8% of their works
- 5Ophthalmology8% of their works
- 6Nephrology6% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Peroxisome Proliferator-Activated Receptors
- Antifungal resistance and susceptibility
- Drug-Induced Ocular Toxicity
- Systemic Sclerosis and Related Diseases
- Antibiotics Pharmacokinetics and Efficacy
Which keywords describe Marshall R. Sack's research?
The keywords of their largest research topics: Inflammation, Cardiovascular Risk, Autoantibodies, Biological Therapy, Rheumatoid Arthritis, Cancer, Cyclooxygenase-2 Inhibitors and Cytochrome P450.
- Retinopathy
- PPARs
- Fibrosis
- Chloroquine
- Antibiotic Pharmacokinetics
- Cytochrome P450
- Cancer
- Biological Therapy
- Cardiovascular Risk
- Inflammation
- Autoantibodies
- Rheumatoid Arthritis
- Cyclooxygenase-2 Inhibitors
- Pharmacogenetics
- Candidiasis
- Critically Ill Patients
- Invasive Fungal Infections
- Peroxisome Proliferator-Activated Receptors
- Systemic Sclerosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Inflammation123 topics
- Cardiovascular Risk102 topics
- Autoantibodies82 topics
- Biological Therapy61 topic
- Rheumatoid Arthritis61 topic
- Cancer41 topic
- Cyclooxygenase-2 Inhibitors41 topic
- Cytochrome P45031 topic
- Pharmacogenetics31 topic
- Antibiotic Pharmacokinetics21 topic
- Candidiasis21 topic
- Chloroquine21 topic
- Critically Ill Patients21 topic
- Fibrosis21 topic
- Invasive Fungal Infections21 topic
- PPARs21 topic
- Peroxisome Proliferator-Activated Receptors21 topic
- Retinopathy21 topic
- Systemic Sclerosis21 topic
Where does Marshall R. Sack work?
Marshall R. Sack's main affiliation in the publication record is Orlando Clinical Research Center, United States.
How many publications and citations does Marshall R. Sack have?
OpenAlex counts 18 works and 1,087 citations for Marshall R. Sack, an h-index of 14, ranking #2,213,311 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Marshall R. Sack. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.